Immunogenics Expert to Co-Lead Pediatric Cancer Dream Team

by St. Baldrick's Foundation
April 7, 2013

Formerly known as the St. Baldrick’s – Stand Up to Cancer Pediatric Cancer Dream Team, this team is now the St. Baldrick’s EPICC Team (Empowering Pediatric Immunotherapies for Childhood Cancer).


Dr. Crystal L. Mackall, co-leader of the SU2C-St. Baldrick’s Pediatric Cancer Dream Team

Dr. Crystal Mackall and Dr. John Maris will co-chair the SU2C-St. Baldrick’s Foundation Immunogenomics Dream Team.

Mackall is an internationally recognized expert in human immunology and has led a cutting-edge translational immunotherapy research program for pediatric sarcomas. She is credited with fundamental discoveries regarding T cell homeostasis and has led the clinical development of recombinant human IL-7, the most potent immunorestorative identified thus far. As Chief of the Pediatric Oncology Branch at the NCI, she leads a diverse translational research program focused on the most challenging of pediatric cancers, and also serves on numerous steering committees and advisory boards focused on translational research.

Years before becoming the co-chair of the SU2C-St. Baldrick’s Foundation Pediatric Cancer Dream Team, Mackall spoke highly of the St. Baldrick’s Foundation, “I consider St. Baldrick’s the most forward looking and robust philanthropic foundation for childhood cancer,” she said.

Support the Pediatric Cancer Dream Team – make a donation today.